Correlation Between Inozyme Pharma and Scholar Rock
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Scholar Rock at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Scholar Rock into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Scholar Rock Holding, you can compare the effects of market volatilities on Inozyme Pharma and Scholar Rock and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Scholar Rock. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Scholar Rock.
Diversification Opportunities for Inozyme Pharma and Scholar Rock
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Inozyme and Scholar is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Scholar Rock Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scholar Rock Holding and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Scholar Rock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scholar Rock Holding has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Scholar Rock go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Scholar Rock
Given the investment horizon of 90 days Inozyme Pharma is expected to generate 2.95 times less return on investment than Scholar Rock. But when comparing it to its historical volatility, Inozyme Pharma is 3.3 times less risky than Scholar Rock. It trades about 0.05 of its potential returns per unit of risk. Scholar Rock Holding is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 767.00 in Scholar Rock Holding on August 26, 2024 and sell it today you would earn a total of 2,225 from holding Scholar Rock Holding or generate 290.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Scholar Rock Holding
Performance |
| Timeline |
| Inozyme Pharma |
| Scholar Rock Holding |
Inozyme Pharma and Scholar Rock Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Scholar Rock
The main advantage of trading using opposite Inozyme Pharma and Scholar Rock positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Scholar Rock can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scholar Rock will offset losses from the drop in Scholar Rock's long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Scholar Rock vs. Revolution Medicines | Scholar Rock vs. Black Diamond Therapeutics | Scholar Rock vs. Passage Bio | Scholar Rock vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |